Family Medicine Commons^™

Gritty Residents: Starting Residency With Resiliency, R Levi Sundermeyer, Brock Cardon

Continental and Mountain Divisions GME Resarch Day 2026

No abstract provided.

Making The Most Out Of Advanced Directives: A Qi Project, Brissa Mundo-Santacruz, Joseph Freeze, Jesus Dorado, Nina Ball

Continental and Mountain Divisions GME Resarch Day 2026

No abstract provided.

A Joint Effort: Quality Improvement Using Joint Injection Drawers, Grant Thomas, Brissa Mundo-Santacruz, Joseph Freeze, Talon Aitken, Nina Ball

Continental and Mountain Divisions GME Resarch Day 2026

No abstract provided.

Pulmonary Cystic Echinococcosis In An Immigrant Adolescent: Diagnostic And Therapeutic Challenges In A Non-Endemic Rural Setting, Alexander Cummock, Nathan Cross

Continental and Mountain Divisions GME Resarch Day 2026

No abstract provided.

Strep Pasteurianus Toxic Shock Syndrome Revealing Colon Adenocarcinoma, Kendal Hansen, Enrique Urrutia

West Florida Division GME Research Day 2026

No abstract provided.

Use Of Preference Signals In Family Medicine Residency Recruitment, John E. Snellings, Hanwen Miao, Daniel L. Meyer, Miranda A. Moore

Department of Family and Community Medicine Faculty Publications

Background and Objectives: Increases in graduate medical education application volume led to the introduction of preference signaling—a tool within the Electronic Residency Application Service that allows applicants to signal their sincere interest to a limited number of programs. This study aims to evaluate how family medicine program directors used preference signals during the 2023–2024 recruitment season, the first year this tool was available to family medicine programs. Understanding program director perspectives on preference signal utility is crucial for determining the tool’s impact on the residency selection process.

Methods: Data were collected through the Council of Academic Family Medicine Educational Research …

Education For Residents And Patients On Pain Management For Gyn Procedures, Claire Moen, Jeffrey Edwards, Dominique Rehl, Kenyon Weidle

Continental and Mountain Divisions GME Resarch Day 2026

No abstract provided.

Wernicke Encephalopathy Following Sleeve Gastrectomy: A Case Highlighting The Critical Role Of Vitamin Adherence And Intensive Rehabilitation., Srikrishna Karnatapu, Neha Garg, Arjun Panicker, Francois Du Toit, Chamonix Kinimaka

South Atlantic Division GME Research Days 2026

No abstract provided.

Kawasaki Disease In Disguise: Atypical Presentation In The 5-Month-Old Infant, Grace Mccorkle, Veronica Thompson, Carlos Ojeda, Meghan Rosenquist

South Atlantic Division GME Research Days 2026

No abstract provided.

Insidious Abdominal Pain Masked By Kratom Abuse; A Case Of Lynch Syndrome, Grant Read, Khloe Gu, Jessica Klingensmith, Ameet Patel

West Florida Division GME Research Day 2026

No abstract provided.

The Scope Effect: A Quality Improvement Initiative To Enhance Communication, Awareness, And Connection In Family Medicine Residency, Shana-Kay Lambert-Johnson, Amy Nguyen-Pham, Tasaduq Mir

North Texas GME Research Forum 2026

No abstract provided.

Influenza A Precipitation Of Motor Dysfunction In Dandy-Walker Variant: A Case Of Viral-Induced Spasticity, Scott Scher, Joseph Johnson, Alex Bandea, Tyler Otto, Zarina Marie Guevarra Balde, Abbie John, Carlos Cano

West Florida Division GME Research Day 2026

No abstract provided.

Beyond The Assumption: A Comparison Of Resident And Attending Prescribing Errors In Ambulatory Care, Shana-Kay Lambert-Johnson, Megan Wesling, Keneisha Houston, Isabel Vecino, Tasaduq Mir

North Texas GME Research Forum 2026

BACKGROUND: Medication prescribing errors remain a leading cause of preventable patient harm in ambulatory care. This study examined whether the severity, frequency, and distribution of medication prescribing errors differ between residents and attendings in outpatient settings to inform graduate medical education (GME) and system-level medication safety strategies.

METHODS: This retrospective observational study was conducted across a multi-specialty ambulatory care network. Ambulatory medication-related events involving residents and attendings occurring between January 1 and December 31, 2025, were identified through voluntary reporting in a cloud-based risk management system. Events were categorized by prescriber role and classified using the National Coordinating Council for …

Concurrent Hnf1a (Mody3) And Pdxi (Mody4) Variants In A Young Adult And Critical Therapeutic Implications, Shay-Kay Lambert-Johnson, Matthew Doan, Megan Wesling

North Texas GME Research Forum 2026

BACKGROUND: Monogenic diabetes accounts for approximately 1–5% of diabetes cases and is frequently misclassified. Maturity-onset diabetes of the young (MODY) includes 14 subtypes with distinct pathophysiology and therapeutic implications. Digenic MODY, caused by pathogenic variants in more than one MODY gene, occurs in well under 1% of cases and poses unique diagnostic and management challenges. We report the first known case of concurrent HNF1A (MODY3) and PDX1 (MODY4) mutations, highlighting important clinical and therapeutic considerations.

CASE PRESENTATION: A 19-year-old male with digenic MODY due to MODY3 (HNF1A) and MODY4 (PDX1) mutations presented for team-based adult outpatient diabetes management following transition …

Efficacy Of Zuranolone In The Treatment Of Postpartum Depression: An Evidence-Based Review, Shana-Kay Lambert-Johnson, Tasaduq Mir

North Texas GME Research Forum 2026

BACKGROUND: Postpartum depression (PPD) is a common and potentially severe condition frequently managed in primary care, where delayed treatment adversely affects maternal and infant outcomes. Neuroactive steroid therapies targeting γ-aminobutyric acid type A receptors represent a novel therapeutic class. Brexanolone, the first FDA-approved treatment for PPD, required prolonged inpatient administration and was withdrawn from the U.S. market in 2025. Zuranolone is currently the only FDA-approved medication specifically indicated for PPD, offering a short-course oral treatment suitable for outpatient use. This review evaluated the efficacy of zuranolone and its applicability in primary care practice.

METHODS: This evidence-based review was conducted in …

Rethinking Acute Pain Management: Evidence For Suzetrigine As An Opioid-Sparing Strategy In Outpatient Care, Shana-Kay Lambert-Johnson, Tasaduq Mir

North Texas GME Research Forum 2026

BACKGROUND: The ongoing opioid epidemic underscores the urgent need for effective nonopioid options for acute pain management. Suzetrigine, a selective voltage-gated sodium channel NaV1.8 inhibitor, represents a mechanistically novel analgesic targeting peripheral nociception and may reduce reliance on opioid therapy. It received FDA approval on January 30, 2025, for the treatment of moderate-to-severe acute pain in adults. This evidence-based review evaluates the efficacy and safety of suzetrigine as an opioid-sparing option for outpatient acute pain management.

METHODS: A structured literature search of PubMed was conducted from database inception through January 2026 using the terms “suzetrigine” and “NaV1.8.” Eligible studies were …

Beyond The Temporal Lobe: Atypical Presentation In Adult Hsv-2 Encephalitis, Analekha Chesnick, Michaela Littlefield, Brock Cardon

Continental and Mountain Divisions GME Resarch Day 2026

No abstract provided.

Elevated State Of Mind: A Case Of High-Altitude Worsening Chiari 1 Malformation, Lauren Walters, Brock Cardon, Levi Sundermeyer

Continental and Mountain Divisions GME Resarch Day 2026

No abstract provided.

West Nile Encephalitis Complicated By Urinary Retention, Morgan Reich, Sabra Rahme, Mattie Brand, Jordan Conley

Continental and Mountain Divisions GME Resarch Day 2026

No abstract provided.

Harmonizing Healing: Examining Music Therapy As An Adjunctive Treatment For Mental Health, Shalin Patel, Karen Foote

MidAmerica Division GME Healthcare Symposium 2026

No abstract provided.